FXN and mitochondrial disease: It has been proposed that SDHIs may be harmful to patients with mitochondrial diseases since two SDHBIs, bixafen and fluxapyroxad, were shown to cause apoptosis in cells from patients with Friedrich ataxia, a mitochondrial disease caused by mutations in the frataxin gene [89].